Retatrutide calculator

How to reconstitute retatrutide

Reconstitution means adding a sterile diluent to a freeze-dried (lyophilized) powder. Bacteriostatic Water for Injection is a sterile multi-dose diluent containing 0.9% benzyl alcohol; use it only when it is appropriate for the contents of your vial. The diluent and storage instructions supplied with a specific product take priority.

Choose the diluent volume

Most peptide vials hold no more than 3 mL. If you do not have a different volume specified, 2 mL is a practical default: it fits most vials and usually produces a concentration that is straightforward to measure on an insulin syringe. Do not add more liquid than the vial can hold, and do not use tap, bottled, or other non-sterile water.

The amount of diluent changes the concentration, not the total amount of peptide in the vial. More liquid creates a lower concentration and a larger syringe draw for the same dose; less liquid creates a higher concentration and a smaller draw. Enter different water volumes in the calculator above before mixing to compare the resulting concentration and draw.

A vial may still look partly empty after reconstitution because the lyophilized powder occupies very little space. The dose is determined by the concentration you created—not by how full the vial looks.

1. Prepare a clean work area. Wash and dry your hands. Gather the vial, the correct sterile diluent, alcohol swabs, new sterile syringes and needles, and a sharps container.
2. Inspect the vial and diluent. Check the names, amounts, expiration dates, seals, and expected appearance. Do not use a container with a damaged seal or visible contamination.
3. Record the planned volume. Use the calculator to confirm the concentration and draw volume, then write down the vial amount and exact diluent volume before you begin.
4. Clean the vial stoppers. Wipe each rubber stopper with a fresh alcohol swab and let it dry completely. Avoid touching the cleaned surface.
5. Draw the diluent. With a new sterile syringe and needle, draw the exact volume you selected. Remove large air bubbles so the transferred volume remains accurate.
6. Add it slowly along the vial wall. Direct the stream down the inside glass rather than forcefully onto the powder. This reduces foaming and agitation.
7. Gently swirl until dissolved. Rotate or roll the vial gently. Do not shake it. Let any foam settle, then inspect the solution for undissolved material, particles, cloudiness, or unexpected color.
8. Label the finished vial. Record the peptide amount, diluent and volume, resulting concentration, mixing date, and the storage or discard date that applies to that formulation.

Storage and when to discard it

Storage temperature and usable life after mixing depend on the peptide, diluent, sterility, and formulation. Bacteriostatic water allows repeated withdrawals from its own container, but it does not create a universal 4- or 6-week stability period for everything mixed with it. Use the storage conditions and beyond-use date supplied for the product. Discard a mixed vial if that date passes or if the seal is damaged, the solution changes appearance, or contamination is possible.

How to draw from a vial

First confirm that the calculator result matches the syringe in your hand. On a U-100 syringe, 100 units equals 1 mL; other syringe types use different markings.

1. Start with clean hands and a new sterile syringe and needle. Never reuse a needle or syringe and never share injection equipment.
2. Clean the vial stopper with a fresh alcohol swab and let it dry.
3. Draw air into the syringe equal to the liquid volume you plan to withdraw. Insert the needle through the stopper and push that air into the upright vial without forcing or over-pressurizing it.
4. Invert the vial and keep the needle tip below the liquid surface.
5. Pull back slowly to just past the target mark. Tap bubbles toward the needle and push the air and excess liquid back into the vial.
6. Read the final volume at eye level. Align the correct edge of the plunger with the target line, confirm the units and volume one more time, and then remove the needle.
7. Dispose of used sharps promptly. After one use, place the needle and syringe in an FDA-cleared sharps container. Do not leave loose needles in household trash or recycling.

Where people buy it, and what those sellers publish

Retatrutide is not available on prescription, so the material people reconstitute comes from research-chemical sellers whose published evidence varies widely. Our retatrutide supplier comparison records what twenty of the most visible sellers actually publish: whether a purity report is hosted by the testing laboratory or only by the seller, listed prices per milligram, and stock.

The single most useful column is where the report lives. A result published at the laboratory’s own verification address, indexed by a report number, is one you can open and read yourself; a PDF hosted on the seller’s domain cannot be checked that way, and an image of a certificate cannot be checked at all. Evo does not sell peptides and takes no commission from anyone listed.

What the Phase 2 retatrutide study actually tested

Retatrutide has no FDA-approved starting, titration, or maintenance dose. In the published Phase 2 obesity study, researchers assigned participants to target-dose groups of 1 mg, 4 mg, 8 mg, or 12 mg once weekly. Some groups used different protocol-defined starting and escalation regimens.

That design does not form a universal ladder to 12 mg. The 12 mg group was one experimental arm, while 4 mg and 8 mg were also studied target doses. Calling 12 mg “maintenance” was misleading, so Evo does not reproduce the trial as a personal dosing chart.

Response and tolerability are evaluated over time in clinical research and clinical care. The Phase 2 results provide context for the dose ranges studied, but they do not establish 12 mg—or any other single dose—as a default maintenance target.

Understanding the calculation

Concentration equals the amount in the vial divided by the liquid volume. For example, adding 2 mL to a 10 mg vial produces 5 mg/mL. A 2.5 mg dose at that concentration occupies 0.5 mL.

On a U-100 syringe, 1 mL is marked as 100 units, so 0.5 mL is 50 units. “Units” describe volume, not medication amount: the same unit mark can contain a different amount when the concentration changes.

Frequently Asked Questions

Sources

• Jastreboff et al., NEJM (2023): Phase 2 retatrutide obesity trial
• CDC: Preventing unsafe injection practices
• DailyMed: Bacteriostatic Water for Injection, USP
• DailyMed: Example instructions for reconstituting a lyophilized injectable
• FDA: Safe disposal of needles and other sharps
• Poison Control: Get help for a possible medication error